ClinicalTrials.Veeva

Menu

Minor Traumatic Brain Injury : MRI Examination of Consequences and Social Insertion (TRACE)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Terminated

Conditions

Traumatic Brain Injury

Treatments

Radiation: Magnetic Resonance Imaging

Study type

Interventional

Funder types

Other

Identifiers

NCT04364568
38RC19.305

Details and patient eligibility

About

Minor traumatic brain injury (mTBI) (Glasgow Coma Scale 13 to 15) represent 70 to 90% of traumatic brain injury. Different disorders may occur after a traumatic minor brain injury (somatic, cognitive or affective) within 2 weeks.

For 10 to 20% these symptoms are persistent and are part of post-concussion syndrome. Today a small amount of tools to predict this syndrome are available. Cerebral CT scan, a routine test for mTBI, isn't relevant to predict the post concussion syndrome.

In order to improve understanding of the evolution toward this complication, it seems relevant to run a multimodal study.

Multiparameter MRI combined to psychological and sociological evaluations cold provide a better global perception.

Enrollment

11 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who answered to psychological questionnaires 3 month after mTBI
  • Patients with mTBI according to European Federation of Neurological Societies
  • Initial CT scan indication according to 2012 French Society of Emergency Medicine and European Federation of Neurological Societies
  • Health insurance
  • Written consent

Exclusion criteria

  • Under 18 years
  • Psychiatric or neurologic history with long term treatment
  • Hospitalization due to extra-cranial wounds or intoxication (except alcool)
  • MTBI due to aggression
  • MRI contraindication
  • Inability to understand french language
  • Pregnant or breastfeeding women
  • Incapacitated patients in accordance with article L 1121-5 to L1121-8 of the public health code
  • Patients in another study's exclusion time
  • Inability to have a follow-up
  • Patients who can't be reached in case of emergency

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

11 participants in 2 patient groups

Symptomatic group at three month
Experimental group
Description:
Rivermead Post-Concussion Syndrome \>= 12 MRI and clinical exam and sociological interview at day 105 (+/-15 days) 6 months follow up : sociological interview 1 year follow up : psychological and sociological interview, Rivermead Post Concussion Syndrome questionnaire
Treatment:
Radiation: Magnetic Resonance Imaging
Asymptomatic group at three month
Experimental group
Description:
Rivermead Post-Concussion Syndrome \< 12 MRI and clinical exam and sociological interview at day 105 (+/-15 days) 6 months follow up : sociological interview 1 year follow up : psychological and sociological interview, Rivermead Post Concussion Syndrome questionnaire
Treatment:
Radiation: Magnetic Resonance Imaging

Trial contacts and locations

1

Loading...

Central trial contact

Marion RICHARD; Jean François PAYEN, Pr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems